MLL5/KMT2E Antikörper
Kurzübersicht für MLL5/KMT2E Antikörper (ABIN7261988)
Target
Alle MLL5/KMT2E (MLL5) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Produktmerkmale
- Polyclonal Antibody
-
Aufreinigung
- Affinity purification
-
Immunogen
- Recombinant fusion protein of human KMT2E (NP_061152.3).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IHC 1:50-1:200 IF 1:50-1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- MLL5/KMT2E (MLL5) (Myeloid/lymphoid Or Mixed-Lineage Leukemia 5 (Trithorax Homolog) (MLL5))
-
Andere Bezeichnung
- KMT2E
-
Hintergrund
- This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a protein with an N-terminal PHD zinc finger and a central SET domain. Overexpression of the protein inhibits cell cycle progression. Alternate transcriptional splice variants have been characterized.
-
Gen-ID
- 55904
-
UniProt
- Q8IZD2
-
Pathways
- Retinoic Acid Receptor Signaling Pathway, Warburg Effekt
Target
-